Paper Details

  1. Home
  2. Paper Details

Adjuvant endocrine therapy compared with no systemic therapy for elderly women with early breast cancer: 21-year results of International Breast Cancer Study Group Trial IV.

Author: , Castiglione-GertschMonica, CoatesAlan S, CollinsJohn, CrivellariDiana, FeyMartin F, GelberRichard D, GoldhirschAron, LindtnerJurij, PriceKaren, RudenstamCarl-Magnus, SennHans-Jörg

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Research Support, U.S. Gov't, P.H.S.Research funding provided by the Public Health Service (PHS).

Overview

The study reviewed the long-term outcome of a trial comparing endocrine treatment versus no adjuvant therapy in older women with node-positive breast cancer, highlighting the continued debate about the role of adjuvant therapy in this population.
Paper Details　
Original Abstract of the Article :
Increasing numbers of older women are affected by early breast cancer, because of prolonged life expectancy and the increasing incidence of breast cancer with age. The role of adjuvant therapy for this population is still a matter of debate. We reviewed the long-term outcome of a mature trial compar...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/14673038

データ提供：米国国立医学図書館（NLM）

Endocrine Therapy: A Desert Oasis for Older Women with Breast Cancer?

Breast cancer is a common concern for women, and its impact on older women is a topic of increasing research interest. This study explores the role of adjuvant endocrine therapy, a hormonal treatment, in older women with early-stage breast cancer. The researchers reviewed long-term data from a clinical trial comparing endocrine therapy with no systemic therapy in older women with node-positive breast cancer.

Endocrine Therapy: A Promising Strategy for Older Women with Breast Cancer

The study's findings suggest that endocrine therapy may be a valuable treatment option for older women with early-stage breast cancer, offering a potential desert oasis for these patients. The long-term results showed a significant benefit from endocrine therapy, with improved outcomes for patients who received this treatment.

Navigating Breast Cancer Treatment with Confidence

This study provides valuable information for older women with early-stage breast cancer. Endocrine therapy may be a viable treatment option, offering hope and improved outcomes. It's important to remember that breast cancer treatment is a complex and personal journey. It's essential to discuss treatment options with your doctor to create a plan that best addresses your individual needs and preferences.

Dr. Camel's Conclusion

The long-term results of this study highlight the potential benefits of adjuvant endocrine therapy in older women with early-stage breast cancer. The findings suggest that endocrine therapy can be a valuable tool in the fight against breast cancer, offering hope for improved outcomes. Like a camel navigating the vast desert, we must always seek the best possible treatment strategies to ensure optimal care for patients with breast cancer.

Date :
  1. Date Completed 2004-02-13
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

14673038

DOI: Digital Object Identifier

JCO.2003.03.559

Related Literature

Article Analysis
・Effective treatment of breast cancer
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.